New · GLP-1 pills · From $149/mo→Learn more
clyne™
Concierge
SCIENCE · TRANSPARENCYMODEL CARD · TRIAL TAPE · ERRATAUPDATED Q2 2026
00 / SHOW YOUR WORK

Trust is earned with receipts.

Most telehealth marketing reads like a vibe board. We'd rather you read the system prompt, the trial citations, and the editorial standards. Then decide if we deserve your trust.

01 / CLINICAL EVIDENCE

Every claim has a citation.

We index 27,000+ peer-reviewed abstracts. Our physicians review every Rx with the trial in front of them. If we can't cite it, we won't say it.

INDEXED ABSTRACTS27,000+
PARTICIPANTS · GLP-1 TRIALS23,000+
BACKED BY A CITED TRIALEvery Rx
02 / AI MODEL CARD

Open about the system.

A vendor large-language model, prompt-engineered over our trial index and product catalog, with hard escalation triggers and physician override on every prescription. Nothing in the chat ever trains the model.

AVG TIME TO FIRST TOKENSub-2s
ESCALATION ON CLINICAL QHard
MEMBER DATA TRAINED ONZero
03 / EDITORIAL STANDARDS

We hold ourselves to NEJM rules.

Conflicts disclosed. Authorship signed. Numbers cited. We never market off-label uses, hide trial nuances, or rebrand bro-science as protocol.

BY LICENSED PHYSICIANSReviewed
CORRECTIONS LOGOpen
EVERY MED CLAIMCited
01 / TRIAL TAPE

A live citation feed.

UPDATED WHEN A NEW TRIAL CHANGES PROTOCOL
TRIALSOURCE
STEP 1Semaglutide 2.4 mg in obesity−14.9% body weight · 68 wkNEJM 2021
PIONEER 4Oral semaglutide vs liraglutide−15.1% body weight · 68 wkLancet 2023
SELECTSemaglutide & cardiovascular outcomes−20% MACE riskNEJM 2023
Trial of finasteride for AGA5α-reductase blockade+86% terminal hair · 12 moJAAD 1998
Tadalafil PD-5 inhibitorED in men 40++57% successful intercourseJAMA 2003
Horvath DNAm clockEpigenetic age estimationr=0.96 vs chronological ageGenome Biol 2013
02 / MODEL CARD

The system prompt is not a secret.

SYSTEM_PROMPT

You are Clyne Concierge, a clinical assistant for the Clyne telehealth platform. You speak with the
calm authority of a knowledgeable friend, not a hospital pamphlet. Cite trials, percentages,
and mechanisms when you have them. Be honest about limits: note when something is medical
advice vs. information. Never market off-label uses. Always escalate to a physician licensed in your state
for prescriptions, anything new about a controlled substance, or anything outside your guardrail
catalogue. Do not train on this conversation.
MODEL
Claude 4.5 Sonnet
RETRIEVAL
Semantic search over the Clyne treatment catalog
GUARDRAILS
Hard escalation on Rx + controlled substances
PRIVACY
Zero training on member data
03 / EDITORIAL STANDARDS

We hold ourselves to journal rules.

AUTHORSHIP
Every clinical page lists the reviewing physician + license #.
CONFLICTS
Compounding pharmacies, manufacturers, employees: all disclosed.
OFF-LABEL
We never market off-label. Off-label Rx is physician-directed, in writing.
ERRATA
If we get something wrong, the correction goes on the page in 48 hours.
TRIAL NUANCE
We surface dropouts, side-effect profiles, and trial demographics.
AUDIT
Quarterly external review by a board-certified academic clinician.
ERRATA · NONE OPEN
Spotted something we got wrong?
For clinical or editorial inquiries, mail support@clynehealth.com. Confirmed errors are corrected within 48 hours and logged here.
Ask a science question
ASK CLYNE CONCIERGE

Still deciding? Ask Clyne Concierge.

No signup. No gated form. Get an answer in under a minute.